21000 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Growth hormone [GH] (Somatotropin)
Combination therapy
#302Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
#303Activated sialic acid derivatives for protein derivatisation and conjugation
#304Activated sialic acid derivatives for protein derivatisation and conjugation
#305mRNA for use in treatment of human genetic diseases
#306STABILIZED LIQUID FORMULATION
#307Glycosaminoglycan compositions in combination with stem cells
#308Formulation of growth hormone albumin-binder conjugate
#309Particles containing a growth factor, and uses thereof
#310COMPOSITIONS CAPABLE OF FACILITATING PENETRATION ACROSS A BIOLOGICAL BARRIER
#311FORMULATIONS OF AN ALBUMIN hGH FUSION PROTEIN
#312OCULAR DRUG DELIVERY SYSTEM
#313Reversible pegylated drugs
#314Dermal micro-organs, methods and apparatuses for producing and using the same
#315Designer circuit controlling diet-induced obesity
#316Increasing drug affinity for crystalline microparticle surfaces
#317Sialic Acid Derivatives
#318Process for preparing products comprising stabilised actives and compositions comprising same
#319Compositions comprising a polymeric reagent and a pharmacologically active agent
#320FAT LOSS COMPOSITION
#321Release system of hydrophobic proteins
#322Solvent/polymer solutions as suspension vehicles
#323Microfabricated nanopore device for sustained release of therapeutic agent
#324Microfabricated nanopore device for sustained release of therapeutic agent
#325Fatty Acid Acylated Amino Acids for Growth Hormone Delivery
#326STABLE NON-AQUEOUS SINGLE PHASE VISCOUS VEHICLES AND FORMULATIONS UTILIZING SUCH VEHICLES
#327Iron garnet nanoparticles for cancer radiotherapy and chemotherapy
#328CLEANSING COMPOSITION FOR HORMONE DEPOSITION
#329Microfabricated nanopore device for sustained release of therapeutic agent
#330Transgenic microalgae and use thereof for oral delivery of proteins
#331LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME
#332Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery
#333Methods and compositions for oral administration of protein and peptide therapeutic agents
#334STIMULATION OF HUMAN MEIBOMIAN GLAND FUNCTION
#335Liquid formulation of highly concentrated long-acting human growth hormone conjugate
#336Heparosan-polypeptide and heparosan-polynucleotide drug conjugates and methods of making and using same
#337Use of growth hormone fragments
#338Stabilization of Aqueous Compositions of Proteins with Displacement Buffers
#339Method for manufacturing transdermally delivered hyaluronic acid-protein conjugate and transdermally delivered hyaluronic acid-protein conjugate manufactured using same
#340PROCESS FOR THE MANUFACTURING OF A DRUG DELIVERY SYSTEM BASED ON A POLYMER COMPRISING A DISPERSED BIOACTIVE AGENT
#341Pharmaceutical compositions and related methods of delivery
#342Method of treating Crohn's disease by administering an anti-IL-12 antibody
#343Swallowable drug delivery device and method of delivery
#344Internally functionalized graphene substrates
#345Biocompatible particles and method for preparing same
#346mRNA for use in treatment of human genetic diseases
#347TOPICAL DRUG DELIVERY USING PHOSPHATIDYLCHOLINE
#348Combination therapy
#349Growth hormone polypeptides and methods of making and using same
#350METHODS OF TREATING PRADER WILLI SYNDROME AND CONDITIONS ASSOCIATED WITH LOW BASAL METABOLIC RATE OR HYPERPHAGIA USING A KATP CHANNEL OPENER
#351Pastes for injection of a therapeutic agent
#352Methods for treating benign prostatic hypertrophy (BPH)
#353Method for treating breast cancer with prolactin receptor agonists
#354Protein Carrier-Linked Prodrugs
#355Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
#356Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#357Use of RANK/RANKL antagonists for treating muscular dystrophy
#358Modified Human Growth Hormone Polypeptides and Their Uses
#359Radiation-Sterilized Biodegradable Drug Delivery Composition
#360USE OF GROWTH HORMONE OR GROWTH HORMONE RECEPTOR AGONISTS TO PREVENT OR TREAT STRESS-SENSITIVE PSYCHIATRIC ILLNESS
#361Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
#362Method for delivering a therapeutic agent into the wall of the small intestine
#363Pharmaceutical compositions of conjugates formed from polymer derivatives having particular atom arrangements
#364Device, system and methods for the oral delivery of therapeutic compounds
#365Swallowable drug delivery device and methods of drug delivery
#366Bioresorbable microparticles
#367STABILIZED LIQUID FORMULATION
#368AQUEOUS FORMULATION COMPRISING AT LEAST A NEUTRAL SALT AND A BIOPHARMACEUTICAL PROTEIN
#369Biodegradable Drug Delivery Composition
#370LIPID DEPOT FORMULATIONS
#371FUSION OF HUMAN GROWTH HORMONE AND ALBUMIN FORMULATION AND USES THEREOF
#372Use of inhalable powder formulation comprising growth hormone for preventing or treating NMDA receptor hypofunction-related diseases
#373Dermal micro-organs, methods and apparatuses for producing and using the same
#374Anti-TNF antibodies, compositions, methods and uses
#375Injectable Depot Compositions and Uses Thereof
#376Injectable Depot Composition
#377Vaccine and drug delivery by intranasal application of vector and vector extracts
#378Medical devices and methods comprising an anabolic agent for treatment of an injury
#379OCULAR DRUG DELIVERY SYSTEM
#380MODIFIED-RELEASE MICROPARTICLES BASED ON AMPHIPHILIC COPOLYMER AND ON ACTIVE PRINCIPLE(S) AND PHARMACEUTICAL FORMULATIONS COMPRISING THEM
#381Complexation of Metal Ions with Polypeptides
#382Genomic markers for prediction of long-term response to 2 years of growth hormone (GH) therapy
#383Stabilized Protein Crystals, Formulations Containing Them and Methods of Making Them
#384Microfabricated nanopore device for sustained release of therapeutic agent
#385Microfabricated nanopore device for sustained release of therapeutic agent
#386ABSORPTION OF THERAPEUTIC AGENTS ACROSS MUCOSAL MEMBRANES OR THE SKIN
#387Microfabricated nanopore device for sustained release of therapeutic agent
#388Growth hormone and interferon-alpha 2 glycoproteins produced in plants
#389Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery
#390Method of treatment of small for gestational age infants under two years of age
#391Swallowable drug delivery device and method of delivery
#392Particles containing a growth factor, and uses thereof
#393Methods of delivering stable topical drug compositions
#394Methods of delivering stable topical drug compositions
#395TOPICAL DRUG DELIVERY USING PHOSPHATIDYLCHOLINE
#396Compositions for nasal administration of pharmaceuticals
#397Compositions and Methods for the Diagnosis and Treatment of Primary Insulin-Like Growth Factor Deficiency (PIGFD) and Idiopathic Short Stature (ISS)
#398Sustained-release pharmaceutical composition
#399Methods for making proteins containing free cysteine residues
#400Microfabricated nanopore device for sustained release of therapeutic agent
#401Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
#402Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences
#403Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#404Device, system and methods for the oral delivery of therapeutic compounds
#405METHOD OF TREATING HUMAN GROWTH HORMONE MEDIATED CONDITION
#406Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#407Method for treating psoriatic arthritis by administering an anti-IL-12 antibody
#408Liquid formulation of long-acting human growth hormone conjugate
#409Dermal micro-organs, methods and apparatuses for producing and using the same
#410TREATMENT OF SEPSIS AND SEPTIC SHOCK USING GHRELIN AND GROWTH HORMONE
#411Pharmaceutical compositions containing at least one protein active ingredient protected from digestive enzymes
#412Dermal micro-organs, methods and apparatuses for producing and using the same
#413GROWTH HORMONE RECEPTOR DEFICIENCY CAUSES A MAJOR REDUCTION IN PRO-AGING SIGNALING, CANCER AND DIABETES IN HUMANS
#414Method for sensitizing cancer stem cells to cancer therapy
#415Solvent/polymer solutions as suspension vehicles
#416PHARMACEUTICAL COMPOSITION FOR TREATMENT OF THROMBOSIS-RELATED DISEASES COMPRISING A FRAGMENT OF PROLACTIN (PRL)-GROWTH HORMONE (GH)-PLACENTAL LACTOGEN (PL)-FAMILY PROTEIN
#417Solvent/polymer solutions as suspension vehicles
#418Regeneration and repair of neural tissue using postpartum-derived cells
#419METHODS TO FACILITATE TRANSMISSION OF LARGE MOLECULES ACROSS THE BLOOD-BRAIN, BLOOD-EYE, AND BLOOD-NERVE BARRIERS
#420Prolactin Induced Increase in Neural Stem Cell Numbers
#421Dry growth hormone composition transiently linked to a polymer carrier
#422REMEDY FOR CARTILAGE-RELATED DISEASES
#423Phospholipid depot
#424Dermal micro-organs, methods and apparatuses for producing and using the same
#425USE OF INHALABLE POWDER FORMULATION COMPRISING GROWTH HORMONE FOR PREVENTING OR TREATING NMDA RECEPTOR HYPOFUNCTION-RELATED DISEASES
#426Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure
#427Anti-TNF antibodies, compositions, methods and uses
#428Glycosaminoglycan compositions in combination with stem cells
#429Medical devices and methods comprising an anabolic agent for wound healing
#430FORMULATION FOR HGH AND RHIGF-1 COMBINATION
#431Lipid depot formulations
#432Medical compositions containing ghrelin
#433Solvent/polymer solutions as suspension vehicles
#434Transdermal therapeutic system for the administration of peptides
#435Methods and compositions for treating post-myocardial infarction damage
#436Methods for treatment of insulin-like growth factor-1 deficiency
#437Biodegradable Drug Delivery Composition
#438Process for preparing products comprising stabilised actives and compositions comprising same
#439Methods and assays for treating subjects with SHANK3 deletion, mutation or reduced expression
#440Viral vector encoding a toll-like receptor and encoding a toll-like receptor agonist
#441Method for treating psoriasis by administering an anti-IL-12 antibody
#442Dermal micro-organs, methods and apparatuses for producing and using the same
#443Compositions and methods for treating growth hormone deficiency
#444Modified human interferon polypeptides and their uses
#445mRNA for use in treatment of human genetic diseases
#446Method for increasing muscle mass and strength
#447COMPLEXATION OF METAL IONS WITH POLYPEPTIDES
#448Dermal micro-organs, methods and apparatuses for producing and using the same
#449Pharmaceutical compositions and related methods of delivery
#450Human Growth Hormone Formulations
#451Polypeptide protracting tags
#452Methods of lysosomal storage disease therapy
#453Colloidal Liposomal Compositions and Methods
#454Method for reducing immunogenicity of therapeutic protein compositions
#455Methods for making proteins containing free cysteine residues
#456Swallowable drug delivery device and method of delivery
#457Pharmaceutical compositions and related methods of delivery
#458Dermal micro-organs, methods and apparatuses for producing and using the same
#459Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
#460Modified Human Growth Hormone
#461RECOMBINANT FUSION PROTEINS TO GROWTH HORMONE AND SERUM ALBUMIN
#462Prolactin induced increase in neural stem cell numbers
#463Solvent/polymer solutions as suspension vehicles
#464PHARMACEUTICAL COMPOSITIONS OF SOMATOTROPHIC HORMONES
#465PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#466HUMAN GROWTH HORMONE AQUEOUS FORMULATION
#467Glycoproteins Produced in Plants and Methods of Their Use
#468Sialic acid derivatives
#469Microfabricated nanopore device for sustained release of therapeutic agent
#470Nucleic acid for plant expression of a fusion protein comprising hydroxyproline O-glycosylation glycomodule
#471Formulations of Human Growth Hormone Comprising a Non-Naturally Encoded Amino Acid
#472Methods for forming polymer-drug conjugates
#473Absorption of therapeutic agents across mucosal membranes or the skin
#474REDUCING DRUG DEPENDENCE OR ADDICTION
#475Swallowable drug delivery device and methods of drug delivery
#476Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#477COMPOSITIONS AND METHODS FOR ORAL DRUG DELIVERY
#478Topical drug delivery using phosphatidylcholine
#479Method Of Delivering Stable Topical Drug Compositions
#480PEGylated recombinant human growth hormone compounds
#481Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles
#482COMPOSITIONS AND METHODS OF STEM CELL THERAPY FOR AUTISM
#483PEPTIDE-POLYMER CONJUGATES
#484COMPOSITION TO BE ABSORBED THROUGH MUCOUS TISSUE
#485Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growrh factors of stem cells
#486STABILIZATION OF HYDROPHOBIC PROTEIN THERAPEUTIC AGENTS
#487Sialic acid derivatives for protein derivatisation and conjugation
#488Intracutaneous paste composition
#489Short duration depot formulations
#490METHOD FOR TREATMENT OF MACULAR DEGENERATION USING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE
#491Stable formulation of growth hormone comprising lactate anion
#492Methods for Therapeutic Treatment of Benign Prostatic Hypertrophy (BPH)
#493Stabilisation of Proteins
#494Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof
#495Stabilizing alkylglycoside compositions and methods thereof
#496Therapy of neurological inflammatory diseases with (5'-deoxy-5'-adenosyl) cobamamide, recombinant human growth hormone, interleukins IL-1, IL-6, IL-11, epidermal growth factor, and physiotherapy
#497Transdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
#498Microparticle and pharmaceutical composition thereof
#499Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
#500INJECTION VEHICLE FOR POLYMER-BASED FORMULATIONS
#501Solid lipid microcapsules containing growth hormone inner core microparticles
#502COMBINATION OF PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND HUMAN GROWTH HORMONE FOR THE TREATMENT OF MUSCLE ATROPHY AND RELATED DISORDERS
#503Methods and compositions for oral administration of protein and peptide therapeutic agents
#504SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#505TOPICAL DRUG DELIVERY USING PHOSPHATIDYLCHOLINE
#506Use of VWF stabilized FVIII preparations and of VWF preparations without FVIII for extravascular administration in the therapy and prophylactic treatment of bleeding disorders
#507Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#508METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF INSULIN
#509Recombinant fusion proteins to growth hormone and serum albumin
#510Regeneration and repair of neural tissue using postpartum-derived cells
#511SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF
#512Stabilized protein crystals, formulations comprising them and methods of making them
#513Method of drug formulation of compositions comprising crystalline microparticle surfaces
#514Pharmaceutical compositions comprising hGH for oral delivery
#515METHODS COMPOSITIONS AND ARTICLE OF MANUFACTURE FOR MODULATING BONE GROWTH
#516THERAPEUTIC AGENT FOR VITILIGO AND METHOD OF ACCELERATING PIGMENTATION
#517Modulating bone growth in treating scoliosis
#518Crystallized recombinant human growth factor formulations
#519Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#520Stabilizing alkylglycoside compositions and methods thereof
#521Sustained release formulations comprising very low molecular weight polymers
#522Methods for promoting growth and survival of insulin-secreting cells
#523Complex consisted of a polysaccharide and an HBP
#524Dermal micro-organs, methods and apparatuses for producing and using the same
#525Methods for treatment of insulin-like growth factor-1 deficiency
#526Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
#527PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#528Absorption enhancers such as E.G. BHT, BHA or propyl gallate
#529Reversible pegylated drugs
#530Protein-polymer conjugates
#531Pharmaceutical formulation
#532GLYCOPROTEINS PRODUCED IN PLANTS AND METHODS OF THEIR USE
#533METHODS OF PRODUCING PEPTIDES IN PLANTS AND PEPTIDES PRODUCED THEREBY
#534SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF
#535STABILIZATION OF AQUEOUS COMPOSITIONS OF PROTEINS WITH DISPLACEMENT BUFFERS
#536Stably transformed bone marrow-derived cells and uses thereof
#537Dimeric Prolactin Receptor Ligands
#538Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof
#539Islet cell cluster produced from human umbilical cord mesenchymal stem cells
#540Compounds and compositions for delivering active agents
#541STABILIZING ALKYLGLYCOSIDE COMPOSITIONS AND METHODS THEREOF
#542Liquid formulations N-terminal serine of pegylated growth hormone
#543Compounds and compositions for delivering active agents
#544METHODS FOR INCREASING THE SIZE OF ANIMALS USING NEEDLELESS DELIVERY CONSTRUCTS
#545Stabilizing alkylglycoside compositions and methods thereof
#546Stable liquid formulation of human growth hormone
#547Methods and compositions for needleless delivery of macromolecules
#548Combined Regulation of Neural Cell Production
#549Transglutaminase Mediated Conjugation of Peptides
#550Anti-TNF antibodies, compositions, methods and uses
#551Anti-IL-12 antibodies
#552Stabilizing alkylglycoside compositions and methods thereof
#553COMBINATION OF SOMATOSTATIN-ANALOGS WITH DOPAMINE- OR GROWTH HORMONE RECEPTOR ANTAGONIST
#554METHODS AND PREPARATIONS FOR CURING CRITICALLY ILL PATIENTS
#555Compositons for nasal administration of pharmaceuticals
#556Human growth hormone aqueous formulation
#557Ophthalmic hGM-CSF preparation
#558Salts of potassium ATP channel openers and uses thereof
#559Treatment of sepsis and septic shock using ghrelin and growth hormone
#560Composition and its Therapeutic Use
#561DISPERSANT AGENT FOR SUSTAINED-RELEASE PREPARATIONS
#562Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
#563Polypeptide protracting tags
#564Dermal micro-organs, methods and apparatuses for producing and using the same
#565Growth hormone-containing formulation and method of use
#566Anti-TNF antibodies, compositions, methods and uses
#567Anti-TNF antibodies, compositions, methods and uses
#568METHOD OF PREVENTING AND TREATING ENDOCRINE SYSTEM DISTURBANCES
#569Method of treating mouse carrying human hepatocytes
#570SUBMICRONIZATION OF PROTEINS USING SUPERCRITICAL FLUIDS
#571Liquid kelp formulation with or without enhanced shelf life, and method of making
#572TREATMENT OF DIABETES
#573Liquid Human Growth Hormone Formulation Containing Polyethylene Glycol
#574HIGH MOLECULAR WEIGHT MEDICINE-CONTAINING PREPARATION IN POWDER FORM FOR ADMINISTRATION THROUGH MUCOSA
#575COMPOSITIONS COMPRISING POLYCATION-COMPLEXED PROTEIN CRYSTALS AND METHODS OF TREATMENT USING THEM
#576Nanoparticles for protein drug delivery
#577Transdermal delivery peptides and method of use thereof
#578Modified human four helical bundle polypeptides and their uses
#579Use of natriuretic peptides for the treatment of stature disorders related to shox gene
#580Umbilical Cord Stem Cell Composition & Method of Treating Neurological Diseases
#581Stabilizing alkylglycoside compositions and methods thereof
#582Activated sialic acid derivatives for protein derivatisation and conjugation
#583Oral dosage formulations of protease-resistant polypeptides
#584Human Growth Hormone Treatment Methods
#585Human growth hormone patch formulations
#586Stable non- aqueous single phase viscous vehicles and formulations utilizing such vehicles
#587Stabilized protein crystals, formulations comprising them and methods of making them
#588Treatment of Inclusion Body Myositis
#589Methods for treatment and management of macular degeneration using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
#590Modified Human Four Helical Bundle Polypeptides and Their Uses
#591Compositions and methods for buccal delivery of human growth hormone
#592Prolactin induced increase in neural stem cell numbers
#593Modified human four helical bundle polypeptides and their uses
#594High pressure treatment of proteins for reduced immunogenicity
#595Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
#596Modified Human Four Helical Bundle Polypeptides and Their Uses
#597Methods for preventing or treating bone disorders
#598Stable growth hormone liquid formulation
#599Use of Growth Hormone in Treatment of Long-Bone Fractures
#600METHODS AND DEVICES FOR ADMINISTRATION OF SUBSTANCES INTO THE INTRADERMAL LAYER OF SKIN FOR SYSTEMIC ABSORPTION